Levofloxacin is recommended by the Pediatric Infectious Disease Society and the Infectious Disease Society of America as a first-line treatment for pediatric pneumonia caused by penicillin-resistant "Streptococcus pneumoniae", and as a second-line agent for the treatment of penicillin-sensitive cases.